Press releases

Protein drug development company Mycenax Biotech Inc. (GreTai, Taiwan: 4726) announced today that its rheumatoid arthritis and psoriasis drug TuNEX®, a biosimilar version of etanercept, has successfully completed a Phase I trial in South Korea and Phase I More

An HIV/AIDS vaccine developed by University of Western Ontario professor Chil-Yong Kang has reached "an important milestone" as it pushes towards the first phase of human trials. More

At a forum focusing on allergy causes and treatment strategies held in Taipei, botanically-derived health products company Medigreen Biotechnology unveiled its new anti-allergy formulation More

An HIV/AIDS vaccine developed at The University of Western Ontario is set for the first phase of human trials.

Sumagen Canada today announced it has submitted an Investigational New Drug application to the United States FDA. More

Brescia University College student Jaimie Hemsworth's work in developing and testing supplemented probiotic yogurt for HIV clients has earned her the Morgan Medal for research from the Canadian Foundation for Dietetic Research. More

University of Western Ontario researcher John McCormick has been given a $603,000 boost from the Canadian Institutes of Health Research (CIHR) to investigate how toxic shock syndrome and other severe diseases can be prevented. More

Canada's lacklustre pace in adopting health innovations and commercializing new products and processes is costing our health system, according to organizers of a Richard Ivey School of Business conference taking place next week. More

Lawson Health Research Institute has released their 2009 overview brochure, "Discovery: Thinking Ahead" More

A Memorandum of Understanding between Walpole Island First Nation (WIFN) and The University of Western Ontario has established a policy for all Western researchers who are currently working on collaborative research projects with the WIFN Health Centre. More